We provide you with 20 years of free, institutional-grade data for PTCT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PTCT. Explore the full financial landscape of PTCT stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-07 | 1070081 | PTCT | 10-Q | Url |
| 2025-05-06 | 1070081 | PTCT | 10-Q | Url |
| 2025-02-27 | 1070081 | PTCT | 10-K | Url |
| 2024-11-07 | 1070081 | PTCT | 10-Q | Url |
| 2024-08-08 | 1070081 | PTCT | 10-Q | Url |
| 2024-04-25 | 1070081 | PTCT | 10-Q | Url |
| 2024-02-29 | 1070081 | PTCT | 10-K | Url |
| 2023-10-26 | 1070081 | PTCT | 10-Q | Url |
| 2023-08-03 | 1070081 | PTCT | 10-Q | Url |
| 2023-04-27 | 1070081 | PTCT | 10-Q | Url |
| 2023-02-21 | 1070081 | PTCT | 10-K | Url |
| 2022-10-27 | 1070081 | PTCT | 10-Q | Url |
| 2022-08-04 | 1070081 | PTCT | 10-Q | Url |
| 2022-05-03 | 1070081 | PTCT | 10-Q | Url |
| 2022-02-22 | 1070081 | PTCT | 10-K | Url |
| 2021-10-28 | 1070081 | PTCT | 10-Q | Url |
| 2021-07-29 | 1070081 | PTCT | 10-Q | Url |
| 2021-05-04 | 1070081 | PTCT | 10-Q | Url |
| 2021-02-25 | 1070081 | PTCT | 10-K | Url |
| 2020-10-29 | 1070081 | PTCT | 10-Q | Url |
| 2020-08-05 | 1070081 | PTCT | 10-Q | Url |
| 2020-04-30 | 1070081 | PTCT | 10-Q | Url |
| 2020-03-02 | 1070081 | PTCT | 10-K | Url |
| 2019-10-30 | 1070081 | PTCT | 10-Q | Url |
| 2019-08-06 | 1070081 | PTCT | 10-Q | Url |
| 2019-05-02 | 1070081 | PTCT | 10-Q | Url |
| 2019-03-01 | 1070081 | PTCT | 10-K | Url |
| 2018-11-05 | 1070081 | PTCT | 10-Q | Url |
| 2018-08-07 | 1070081 | PTCT | 10-Q | Url |
| 2018-05-09 | 1070081 | PTCT | 10-Q | Url |
| 2018-03-06 | 1070081 | PTCT | 10-K | Url |
| 2017-11-02 | 1070081 | PTCT | 10-Q | Url |
| 2017-08-09 | 1070081 | PTCT | 10-Q | Url |
| 2017-05-08 | 1070081 | PTCT | 10-Q | Url |
| 2017-03-16 | 1070081 | PTCT | 10-K | Url |
| 2016-11-03 | 1070081 | PTCT | 10-Q | Url |
| 2016-08-04 | 1070081 | PTCT | 10-Q | Url |
| 2016-05-05 | 1070081 | PTCT | 10-Q | Url |
| 2016-02-29 | 1070081 | PTCT | 10-K | Url |
| 2015-11-09 | 1070081 | PTCT | 10-Q | Url |
| 2015-07-31 | 1070081 | PTCT | 10-Q | Url |
| 2015-05-05 | 1070081 | PTCT | 10-Q | Url |
| 2015-03-02 | 1070081 | PTCT | 10-K | Url |
| 2014-11-06 | 1070081 | PTCT | 10-Q | Url |
| 2014-08-07 | 1070081 | PTCT | 10-Q | Url |
| 2014-05-06 | 1070081 | PTCT | 10-Q | Url |
| 2014-03-06 | 1070081 | PTCT | 10-K | Url |
| 2014-01-31 | 1070081 | PTCT | S-1 | Url |
| 2013-11-14 | 1070081 | PTCT | 10-Q | Url |
| 2013-08-13 | 1070081 | PTCT | 10-Q | Url |
| 2013-05-16 | 1070081 | PTCT | S-1 | Url |
| 2006-03-31 | 1070081 | PTCT | S-1 | Url |
PTC Therapeutics, Inc(NASDAQ:PTCT) 
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for the treatment of rare disorders. The company offers Translarna (ataluren) and Emflaza (deflazacort) for the treatment of nonsense mutation Duchenne muscular dystrophy in...
Website: http://www.ptcbio.com
Founded: 1998
Full Time Employees: 754
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about PTCT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.